ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-c
Recalled September 2, 2026 · FDA recall D-0784-2026 · ACCORD HEALTHCARE
Hazard
Subpotent Drug · FDA Class II
Units
N/A
Sold at
Nationwide within the United States
Description
Subpotent Drug
Product
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.
Manufacturer(s)
ACCORD HEALTHCARE, INC.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →